The key finding in this case is the potential role of KDM5A, as cancer cells with elevated KDM5A expression are hypothesized to be more sensitive to chemotherapeutic drugs like etoposide, doxorubicin and cytarabine [7]. The gene discussed is KDM5A; the disease is cancer.